Global Gene Therapies & Associated Vectors Market Report 2022
18 avr. 2022 06h33 HE
|
Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapies & Associated Vectors: Intellectual Property Landscape" report has been added to ResearchAndMarkets.com's offering. Although the...
Genetic Technologies drives leadership in precision medicine with Multi-Risk Test
08 avr. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 08, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG) (“GENE” or the “Company”), a global leader in genomics-based tests in health, wellness...
Insights on the Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Global Market to 2030 - by Scale of Operation, Type of Vector, Application Area, Therapeutic Area and Regions
13 août 2021 04h13 HE
|
Research and Markets
Dublin, Aug. 13, 2021 (GLOBE NEWSWIRE) -- The "Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and...
Global Gene Therapy Market 2021-2027 - COVID-19 Causes Gene Therapy Market to Buckle & Collapse
13 juil. 2021 03h28 HE
|
Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Gene Therapy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global market for Gene Therapy...
Global Gene Therapy Market Report 2021-2025 & 2030: Market is Expected to Reach $12.16 Billion in 2025 at a CAGR of 32%
28 juin 2021 04h38 HE
|
Research and Markets
Dublin, June 28, 2021 (GLOBE NEWSWIRE) -- The "Gene Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global...
Global Gene Therapy Market Report 2020-2027: Market is Projected to Reach a Revised $3.3 Billion
27 nov. 2020 04h18 HE
|
Research and Markets
Dublin, Nov. 27, 2020 (GLOBE NEWSWIRE) -- The "Gene Therapy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. In a Major Setback to the...
Genetic Technologies Announces US Sales Have Commenced via Online Health Platform
11 sept. 2020 08h33 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, “Company”) is delighted to announce that initial sales of its...
US Patent Office Grants Key Risk Test Patent
18 juin 2020 08h00 HE
|
Genetic Technologies Ltd
Issuance of US Patent No: US 10,683,549, Methods for assessing risk of developing breast cancer.Filed provisional patent for its COVID-19 Severity Risk Test, 2020901739 – Methods of assessing risk...
CONTEMPORARY OBSTETRICS AND GYNECOLOGY OF DAYTON ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
30 sept. 2013 10h34 HE
|
Genetic Technologies Group
DAYTON, Ohio, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Contemporary Obstetrics & Gynecology, part of the Providence Medical Group, today announced the availability of the BREVAGen™ predictive risk...
PEARL W. YEE, M.D. INC. OF SAN FRANCISCO ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
16 sept. 2013 10h08 HE
|
Genetic Technologies Group
SAN FRANCISCO, Sept. 16, 2013 (GLOBE NEWSWIRE) -- Pearl Yee, MD, FACOG and clinical professor at the University of California, San Francisco, is pleased to announce that her private practice, Pearl W....